Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
BRIEF-Neurocrine Biosciences Q2 Adjusted EPS USD 2.85 Vs. IBES Estimate USD 1.34

BRIEF-Neurocrine Biosciences Q2 Adjusted EPS USD 2.85 Vs. IBES Estimate USD 1.34

ReutersReuters2026/07/30 20:02

Jul 30 (Reuters) - Neurocrine Biosciences Q2 EPS USD 1.39.

  • Q2 adjusted net income USD 297 million vs. IBES estimate USD 141.4 million
  • Q2 net income USD 144 million
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!